跳至主要内容
临床试验/NCT03893032
NCT03893032Unknown2 期

Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

United States Army Aeromedical Research Laboratory1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年7月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
80
试验地点
1
主要终点
change from baseline in executive function performance

研究概览

简要总结

Considerable research has documented the optimization utility of stimulants in sleep deprived Soldiers and aviators, however, the research for enhancement purposes has demonstrated mixed results. One significant factor that may influence enhancement properties is general intelligence such that low performers exhibit stronger enhancement effects than high performers. The objective of this study is to determine whether stimulants (specifically, modafinil and Adderall) can enhance Soldier cognitive abilities and performance on military tasks. To do so, a within-subjects design will be employed using healthy, rested Soldiers and measuring performance on a set of basic cognitive assessments and operationally relevant tasks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Must be at least 18 years old.
  • Must have normal hearing, vision or corrected to normal vision, and cognitive function as determined by self-report
  • Must have obtained at minimum 6 hours of sleep prior to all testing sessions, as assessed by actigraphy data and self-report. Should the actiwatch malfunction, reliance on self-report will suffice. If the subject does not meet this requirement, he will be asked to reschedule
  • Must have refrained from consumption of stimulants (including caffeine) and over the counter medications which may induce drowsiness for a minimum of 16 hours prior to each test session, and nicotine, 8 hours, prior to all testing sessions, assessed by self-report.

排除标准

  • Currently taking medications which induce drowsiness, such as over-the-counter antihistamines. Any self-medication will be assessed through self-report.
  • No current medical conditions or medications affecting cognitive function or attention as determined by screening by study physician or medical practitioner
  • Current or recent use (as determined by study physician or medical practitioner) of medications that may interact with the test articles. Determined by self-report and exclusion at the discretion of the study physician or medical practitioner.
  • Any history of any attention deficit condition requiring medication. A history of any attention deficit condition with medication is disqualifying as the potential interactions with testing are unknown and would therefore produce a potential source of confounding or bias into the results of the study.
  • Any history of psychological/psychiatric disorder.
  • Any history of addiction or substance abuse as assessed through self-report.
  • Any history of metabolic disorder such as dysthyriodism.
  • Any history of significant cardiovascular disease or hypertension.
  • Any history of hepatic or renal disorder.
  • Females will be excluded given that the drugs administered could potentially negatively impact the very early stages of pregnancy.
  • Any ingestion of substances that may interact with the test articles or potentially skew the results within the last 16 hours prior to testing including over-the-counter medications, supplements, etc. (see attached list to be reviewed with subject).

研究组 & 干预措施

Modafinil 200mg

Experimental

single, 200 mg dose of modafinil

干预措施: Modafinil 200mg (Drug)

mixed amphetamine salts

Experimental

single 10 mg dose of mixed amphetamine salts

干预措施: mixed amphetamine salts (Drug)

placebo

Placebo Comparator

placebo

干预措施: Placebo (Drug)

结局指标

主要结局

change from baseline in executive function performance

时间窗: 2-hours post-dosing

Digit symbol substitution task

change from baseline in working memory performance

时间窗: 2-hours post-dosing

Digit span task

change from baseline in selective attention performance

时间窗: 2-hours post-dosing

Stroop test

change from baseline in sustained attention performance

时间窗: 2-hours post-dosing

Rapid Visual Information Processing Task

change from baseline in marksmanship performance

时间窗: 2-hours post-dosing

number of targets acquired on marksmanship trainer

次要结局

  • change from baseline in risk-taking behavior(2-hours post-dosing)
  • change from baseline in impulsivity(2-hours post-dosing)

研究者

发起方
United States Army Aeromedical Research Laboratory
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Amanda Kelley

Research Psychologist

United States Army Aeromedical Research Laboratory

研究点 (1)

Loading locations...

相似试验